Additive effects of drug transporter genetic polymorphisms on irinotecan pharmacokinetics/pharmacodynamics in Japanese cancer patients
暂无分享，去创建一个
Teruhiko Yoshida | N. Saijo | Y. Ohe | A. Ohtsu | Yoshiro Saito | J. Sawada | Y. Matsumura | T. Hamaguchi | T. Tamura | K. Maekawa | T. Nishimaki-Mogami | Yasuhide Yamada | K. Shirao | H. Kunitoh | N. Kaniwa | H. Minami | N. Yamamoto | K. Sai | Su-ryang Kim | T. Nishimaki‐Mogami | Y. Yamada